Filing Details
- Accession Number:
- 0001453687-23-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-06 17:15:52
- Reporting Period:
- 2023-01-04
- Accepted Time:
- 2023-01-06 17:15:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1453687 | Selecta Biosciences Inc | SELB | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1676930 | Kei Takashi Kishimoto | C/O Selecta Biosciences, Inc. 65 Grove Street Watertown MA 02472 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-04 | 6,381 | $1.13 | 367,719 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-04 | 11 | $1.15 | 367,708 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-05 | 3,372 | $1.13 | 364,336 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-01-05 | 20 | $1.11 | 364,316 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.
Billionaire Hedge Funds
